A person with AIDS affected by Visceral Leishmaniasis: Case Report

The co-infection of Visceral Leishmaniasis (VL) with the acquired immunodeficiency virus (HIV) is critical, due to the concomitant suppression of the immune system and increased mortality, which may be the result of overlapping regions where these organisms are present. This report is about a patien...

Descripción completa

Detalles Bibliográficos
Autores: Feitosa, Itavielly Layany França, Chagas, Fernando Martins Selva, Luna, Fernanda Darliane Tavares de, Almeida Neta, Maria Carmelia, Silva, Mikaelle Ysis da, Matias, Wemerson Neves, Silva, Andressa Pedroza Pereira da, Bezerra, Monnara Lucio da Silva, Pereira , Lívia Costa, Abrantes, Larissa Furtado
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2024
País:Brasil
Institución:Grupo Verde de Agroecologia e Abelhas (GVAA)
Repositorio:Revista Brasileira de Educação e Saúde
Idioma:portugués
OAI Identifier:oai:ojs.gvaa.com.br:article/11045
Acceso en línea:https://www.gvaa.com.br/revista/index.php/REBES/article/view/11045
Access Level:acceso abierto
Palabra clave:Leishmaniose visceral
HIV/AIDS
coinfecção
Descripción
Sumario:The co-infection of Visceral Leishmaniasis (VL) with the acquired immunodeficiency virus (HIV) is critical, due to the concomitant suppression of the immune system and increased mortality, which may be the result of overlapping regions where these organisms are present. This report is about a patient who, despite Acquired Immunodeficiency Syndrome and multiple associated pathologies, socioeconomic vulnerabilities, nutritional deficit, frank VL symptoms and substantial laboratory changes, was successful in treating visceral Leishmaniasis, through treatment with Amphotericin B deoxycholate, Liposomal Amphotericin B, Dolutegravir, Darunavir and Ritonavir, in addition to prophylaxis with Azithromycin and Clindamycin.

Similares en LA Referencia